Blog: Is Allianz hypocritical in dumping Saracens while extending Juventus tie-up?

Allianz Stadium Juventus Turin

As Allianz looks set to end its relationship with Saracens, after extending its Juventus deal, content director Jonathan Swift asks what is worse: salary cap breach or match fixing?

Yesterday Allianz confirmed the extension of their sponsorship of Italian football giants Juventus to 2030 in a deal worth €103.1m (£86.5m).

The news triggered Giacomo Campora, CEO of Allianz S.p.A

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@postonline.co.uk or view our subscription options here: http://subscriptions.postonline.co.uk/subscribe

You are currently unable to copy this content. Please contact info@postonline.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Post? View our subscription options

Q&A: Matt Hicks, Recorder

Matt Hicks, chief commercial officer and co-founder of Recorder, a new London-based insurtech from the creators of Codat, explains how he has built a platform and artificial intelligence co-pilot for brokers.

Brokers want less AI conversation and better service please

Fiona Nicolson reveals brokers want a little less conversation about artificial intelligence and to have a lot more grown-up conversation about balancing online experiences with being able to talk to an insurer's staff at this year’s British Insurance Brokers' Association Conference.

Big Interview: Tara Foley, Axa

Tara Foley, CEO of Axa UK & Ireland, outlines how the business can now do intraday pricing, shares the provider’s growth plans, and reveals how artificial intelligence is changing ways of working at the insurer.

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here